Cadila Healthcare’s Moraiya facility was successfully inspected by the US Food and Drug Administration (USFDA) and there were no observations (483) during the inspection. The inspection was carried out between August 31, 2017 to September 7, 2017.
Cadila Healthcare is part of the Zydus Cadila Group. The company operates in areas of active pharmaceutical ingredients (API) to formulations, and animal health products to cosmeceuticals. Over the last five decades, it has been developing and manufacturing pharmaceutical products and selling and distributing these in over 50 countries around the world.
